TB Research

Population structure and antibiotic resistance profiles ofisolates from Ibadan, Nigeria (2019-2020): a pilot study to improve affordable molecular diagnostic tools.

Elsy Carvajal, Samantha Escandón, Pelumi Daniel Adewole, Bernardo Castro-Rodríguez, Ángel Sebastián Rodríguez-Pazmiño, Solon Alberto Orlando, Alexandra Narvaez, Olumuyiwa Samuel Alabi, et al. (9 authors)

Frontiers in public health · 2025-01

Abstract

Nigeria ranks as the sixth country globally and the first in Africa with the highest burden of tuberculosis (TB) infection. The emergence and spread of multidrug-resistant TB (MDR-TB) strains have posed significant challenges to effective disease management in the country. In this study, 55(MTB) isolates from patients attending a hospital in Ibadan city (Nigeria) were selected. MTB isolates were analyzed using PCR amplification of gene fragments associated with antibiotic resistance, followed by Sanger sequencing and bioinformatics analysis. Additionally, MIRU-VNTR genotyping was performed to address population structure and transmission dynamics. Results show an association between mutations in the,andgenes and phenotypic resistance to rifampicin, isoniazide and fluoroquinolones in a significant percentage of the MTB isolates. However, an extended panel of genes would enable a better characterization of antibiotic resistance. The population structure of MTB in Ibadan, as determined by using MIRU-VNTR, revealed that 96.1% of the strains belong to lineage 4, distributed in the following sublineages: Uganda I (47.1%), LAM (21.6%), Cameroon (17.6%), and Ghana (9.8%). Meanwhile, 3.9% of the strains correspond to lineage 5 (L5), West African-1 sub-lineage. The population structure was very heterogeneous and no active transmission clusters were detected. Overall, this pilot study demonstrated the utility of cost-effective molecular tools in enhancing TB surveillance and control programs in settings where whole-genome sequencing (WGS) is still an economical challenge.

MeSH terms

  • Nigeria
  • Humans
  • Mycobacterium tuberculosis
  • Pilot Projects
  • Tuberculosis, Multidrug-Resistant
  • Male
  • Adult
  • Female
  • Middle Aged
  • Molecular Diagnostic Techniques
  • Antitubercular Agents